81
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand

, , , , , & show all
Pages 167-174 | Published online: 10 Jun 2017

References

  • World Health OrganizationGlobal tuberculosis report 2016 WHO/HTM/TB/2016.13 ed.FranceWorld Health Organization2016
  • World Health OrganizationCompanion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosisGeneva, SwitzerlandWHO Document Production Services2014
  • AhmadSMokaddasECurrent status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosisJ Infect Public Health201472759124216518
  • LiangLWuQGaoLFactors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from ChinaThorax201267763263822403070
  • LangeCAbubakarIAlffenaarJWTBNETManagement of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementEur Respir J2014441236324659544
  • PorwalCKaushikAMakkarNIncidence and risk factors for extensively drug-resistant tuberculosis in Delhi regionPLoS One201382e5529923390524
  • ParamasivanCNLeeEKaoKExperience establishing tuberculosis laboratory capacity in a developing country settingInt J Tuberc Lung Dis2010141596420003696
  • ParsonsLMSomosköviAGutierrezCLaboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesClin Microbiol Rev201124231435021482728
  • BoehmeCCNabetaPHillemannDRapid molecular detection of tuberculosis and rifampin resistanceN Engl J Med2010363111005101520825313
  • World Health OrganizationGuidelines for the programmatic management of drug-resistant tuberculosis – 2011 update Version March 2010. Available from: http://apps.who.int/iris/bitstream/10665/44597/1/9789241501583_eng.pdfAccessed May 17, 2017
  • HeysellSKHouptERThe future of molecular diagnostics for drug-resistant tuberculosisExpert Rev Mol Diagn201212439540522616704
  • LinSYDesmondEPMolecular diagnosis of tuberculosis and drug resistanceClin Lab Med201434229731424856529
  • ChanRCHuiMChanEWGenetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong KongJ Antimicrob Chemother200759586687317360809
  • Hofmann-ThielSvan IngenJFeldmannKMechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, UzbekistanEur Respir J200933236837418829680
  • IlinaENShitikovEAIkryannikovaLNComparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from RussiaPLoS One201382e5657723437175
  • Lopez-AlvarezRBadillo-LopezCCerna-CortesJFFirst insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistanceBMC Microbiol2010108220236539
  • ShermanDRMdluliKHickeyMJCompensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosisScience19962725268164116438658136
  • Almeida Da SilvaPEPalominoJCMolecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugsJ Antimicrob Chemother20116671417143021558086
  • SeifertMCatanzaroDCatanzaroARodwellTCGenetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic reviewPLoS One2015103e011962825799046
  • MiyataMPavanFRSatoDNDrug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methodsBiomed Pharmacother201165645645921880463
  • AmeeruddinNULuke ElizabethHImpact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosisTuberculosis (Edinb)201494655756325270728
  • BanerjeeADubnauEQuemardAinhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosisScience199426351442272308284673
  • LiQJJiaoWWYinQQCompensatory mutations of rifampin resistance are associated with transmission of multidrug-resistant Mycobacterium tuberculosis Beijing genotype strains in ChinaAntimicrob Agents Chemother20166052807281226902762
  • MeftahiNNamouchiAMhenniBBrandisGHughesDMardassiHEvidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strainJ Antimicrob Chemother201671232433226538504
  • PavankumarAREngströmALiuJHerthnekDNilssonMProficient detection of multi-drug-resistant Mycobacterium tuberculosis by padlock probes and lateral flow nucleic acid biosensorsAnal Chem20168884277428426985774
  • HerreraLJiménezSValverdeAGarcía-ArandaMASáez-NietoJAMolecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literatureInt J Antimicrob Agents200321540340812727071
  • PalominoJCMartinADrug resistance mechanisms in Mycobacterium tuberculosisAntibiotics20143331734027025748
  • World Health OrganizationGuidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-plus2001GenevaWorld Health Organization2001 Available from www.WHO_CDS_TB_2001.288_eng.pdfAccessed May 8, 2017
  • Department of Disease Control, Ministry of Public Health, Bangkok, ThailandThe Thailand’s 2008 National MDR-TB Management Guidelines. Bangkok, ThailandThe Bureau of Tuberculosis of Thailand2001 Thai
  • Afanas’evMVIkryannikovaLNIl’inaENMolecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian FederationJ Antimicrob Chemother20075961057106417442757
  • ValvatneHSyreHKrossMIsoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testingJ Antimicrob Chemother200964469470119710078
  • KhadkaDKEampokalapBPanitchakornJRamasootaPKhusmithSMultiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolatesSoutheast Asian J Trop Med Public Health200738237638217539290
  • AungWWEiPWNyuntWWPhenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in MyanmarAnn Lab Med201535549449926206685
  • LuoTZhaoMLiXSelection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, ChinaAntimicrob Agents Chemother20105431075108120008778
  • JagielskiTBakułaZRoeskeKDetection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolatesJ Antimicrob Chemother20146992369237524855126
  • FennerLEggerMBodmerTSwiss HIV Cohort Study and the Swiss Molecular Epidemiology of Tuberculosis Study GroupEffect of mutation and genetic background on drug resistance in Mycobacterium tuberculosisAntimicrob Agents Chemother20125663047305322470121
  • ImperialeBRZumárragaMJDi GiulioABCataldiAAMorcilloNSMolecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugsInt J Tuberc Lung Dis20131781088109323827034
  • NiehausAJMlisanaKGandhiNRMathemaBBrustJCHigh prevalence of inhA promoter mutations among patients with drug-resistant tuberculosis in KwaZulu-Natal, South AfricaPLoS One2015109e013500326332235
  • ZakhamFChaouiIEchchaouiAHDirect sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in MoroccoInfect Drug Resist2013620721324399879
  • TorresJNPaulLVRodwellTCNovel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolatesEmerg Microbes Infect201547e4226251830